| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.23 | 2e-07 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.21 | 7e-06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.12 | 3e-05 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |